Mr. Chungnyeong Kim is a partner at Shin & Kim and his practice focuses on patent, trade secrets, and copyright litigation and advisory services.

Mr. Kim’s expertise centers around patent and trade secret cases, primarily in the pharmaceutical and biotechnology sectors, including patent infringement and invalidation cases related to selection invention and use invention of pharmaceutical products, and trade secret cases related to botulinum toxin. Mr. Kim has also handled a number of intellectual property cases, including a copyright case related to retransmission between a terrestrial broadcasting company and a cable television service provider (SO).

Mr. Kim graduated from Seoul National University College of Pharmacy (summa cum laude), earned his J.D. from Seoul National University School of Law, and is currently a Ph.D. student at Seoul National University School of Law.

• Represented a Korean pharmaceutical company in a Gastiin CR Tab patent infringement litigation.
• Represented a Korean pharmaceutical company in a dolutegravir patent infringement litigation.
• Represented a Korean pharmaceutical company in a diquafosol patent invalidation litigation.
• Represented a Korean pharmaceutical company in amycophenolate patent invalidation litigation.
• Represented a Korean pharmaceutical company in a sitagliptin patent invalidation litigation.
• Represented a Korean pharmaceutical company in a dapagliflozin patent invalidation litigation.
• Represented a Korean pharmaceutical company in a linagliptin patent invalidation litigation.
• Represented a Korean pharmaceutical company in a mirabegron use invention and crystal form invention patent invalidation litigation.
• Represented a Korean pharmaceutical company in a patent invalidation and patent infringement litigation concerning “Cosmetic products with urethane foam which impregnated cosmetic composition.”
• Represented a Korean pharmaceutical company in a patent invalidation litigation related to “polynucleotide fragment complex of fish DNA.”
• Represented a Korean pharmaceutical company in a trade secret civil and criminal cases involving botulinum toxin.
• Represented a Korean media company in a copyright litigation concerning retransmission between a terrestrial broadcasting company and a cable television service provider (SO).